Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)

NCT02044601 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Onartuzumab
DRUG: Erlotinib
DRUG: Paclitaxel
DRUG: Carboplatin
RADIATION: Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]